Creatine Supplementation and Diabetes
Not Applicable
Completed
- Conditions
- DiabetesRenal Function
- Registration Number
- NCT00992043
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The researchers aim to investigate whether this supplement can affect metabolic control in diabetic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- males and females type 2 diabetic patients
- glycated hemoglobin between > 9%
- non insulin users
- physically inactive
- only metformin and/or sulfonylurea users
- BMI > 30 kg/m2
- age of years > 50 y
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method glycated hemoglobin three months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain creatine's glucose tolerance improvement in type 2 diabetes?
How does creatine supplementation compare to metformin in managing type 2 diabetes metabolic control?
Are there specific biomarkers that predict type 2 diabetes patient response to creatine combined with exercise?
What adverse events are associated with creatine supplementation in diabetic patients with renal function concerns?
What combination therapies show enhanced efficacy with creatine for type 2 diabetes management compared to exercise alone?
Trial Locations
- Locations (1)
General Hospital - School of Medicine - University of Sao Paulo
🇧🇷Sao Paulo, Brazil
General Hospital - School of Medicine - University of Sao Paulo🇧🇷Sao Paulo, Brazil